Your browser doesn't support javascript.
loading
In vitro and clinical evaluation of SIG1273: a cosmetic functional ingredient with a broad spectrum of anti-aging and antioxidant activities.
Fernández, José R; Rouzard, Karl; Voronkov, Michael; Huber, Kristen L; Webb, Corey; Stock, Jeffry B; Stock, Maxwell; Gordon, Joel S; Pérez, Eduardo.
Afiliación
  • Fernández JR; Signum Dermalogix, Princeton, NJ, USA.
  • Rouzard K; Signum Dermalogix, Princeton, NJ, USA.
  • Voronkov M; Signum Dermalogix, Princeton, NJ, USA.
  • Huber KL; Signum Dermalogix, Princeton, NJ, USA.
  • Webb C; Signum Dermalogix, Princeton, NJ, USA.
  • Stock JB; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
  • Stock M; Signum Dermalogix, Princeton, NJ, USA.
  • Gordon JS; Signum Dermalogix, Princeton, NJ, USA.
  • Pérez E; Signum Dermalogix, Princeton, NJ, USA.
J Cosmet Dermatol ; 15(2): 150-7, 2016 Jun.
Article en En | MEDLINE | ID: mdl-26754448
BACKGROUND: Isoprenylcysteine (IPC) small molecules were identified as a new class of anti-inflammatory compounds over 20 years ago. Since then, they have been developed as novel cosmetic functional ingredients (CFI) and topical drug candidates. SIG1273 is a second generation CFI that has previously been shown to provide a broad spectrum of benefits for the skin through its anti-inflammatory and antimicrobial properties. OBJECTIVE: To determine whether SIG1273 possesses anti-aging properties in vitro and evaluate the tolerability and activity of SIG1273 when applied topically to human subjects. METHODS: To model photoaging in vitro, human dermal fibroblasts (HDFs) were exposed in culture to UVA to induce collagenase (MMP-1) production. An in vitro wound-healing model was based on the activation of HDF migration into cell-free tissue culture surface. Hydrogen peroxide-induced oxidative stress was performed using HDFs to measure intracellular ROS activity. Radical scavenging capacity was determined using a colorimetric antioxidant assay kit (ABTS method). Lastly, a 4-week, 29-subject study was performed in which SIG1273 was applied topically as a cream to assess its tolerance and activity in reducing the appearance of aging. RESULTS: In vitro studies demonstrate SIG1273 inhibits UVA-induced MMP-1 production, hydrogen peroxide-induced oxidative stress and promotes wound healing. Moreover, SIG1273 was shown to be a radical scavenging antioxidant. Clinical assessment of SIG1273 cream (0.25%) showed it was well tolerated with significant improvement in the appearance of fine lines, coarse wrinkles, radiance/luminosity, pore size, texture/smoothness, hydration and increased firmness. CONCLUSIONS: SIG1273 represents a novel CFI with antioxidant, anti-aging, and anti-inflammatory properties that when applied topically is well tolerated and provides benefits to individuals with aging skin.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oxidación-Reducción / Envejecimiento de la Piel / Satisfacción del Paciente / Cisteína Tipo de estudio: Evaluation_studies / Observational_studies / Prognostic_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: J Cosmet Dermatol Asunto de la revista: DERMATOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oxidación-Reducción / Envejecimiento de la Piel / Satisfacción del Paciente / Cisteína Tipo de estudio: Evaluation_studies / Observational_studies / Prognostic_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: J Cosmet Dermatol Asunto de la revista: DERMATOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos